The TB alliance activity will support research studies to evaluate the safety and efficacy of novel TB drugs and treatment regimens, including the development and regulatory authority approval of…
Ended Cooperative Agreement Awarded Last action
- Award ID
- 7200AA21CA00021
- Recipient
-
The Global Alliance For TB Drug Development Inc. UEI CA1RNRESAZU6
- Awarding agency
-
Bureau for Global Health
Washington Office, US Agency for International Development
- Obligated
- $49,000,000
Award facts
- Assistance listing
- 98.001 USAID Foreign Assistance for Programs Overseas
- Completion date
- Place of performance
- New York, NY 10005, USA
Award details come from USAspending.gov.
Description
The TB alliance activity will support research studies to evaluate the safety and efficacy of novel TB drugs and treatment regimens, including the development and regulatory authority approval of compounds or regimens in clinical phase development. The goal of this activity is to support the discovery of better, faster-acting, and affordable TB drugs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $4,000,000 | |
| Amendment | $6,000,000 | |
| Amendment | $6,000,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $6,000,000 | |
| Amendment | $6,000,000 | |
| Amendment | $6,000,000 | |
| Amendment | $5,000,000 | |
| Amendment | $5,000,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $5,000,000 |
Show all 16
Quick answers
Who received award 7200AA21CA00021?
7200AA21CA00021 was awarded to The Global Alliance For TB Drug Development Inc. by Bureau for Global Health (Washington Office) on September 30, 2021.
How much is award 7200AA21CA00021 worth?
$49,000,000 has been obligated on 7200AA21CA00021.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award